Company
United StatesCharu Aggarwal, MD, MPH, Hematology-Oncology Division, Philadelphia, PA – FDA Inspections
Inspection records and compliance data for Charu Aggarwal, MD, MPH, Hematology-Oncology Division in Philadelphia, Pennsylvania. 2 FDA inspections on record, 1 Form 483, last inspected July 20, 2026.
Company Profile
This profile covers Charu Aggarwal, MD, MPH, Hematology-Oncology Division based in Philadelphia, Pennsylvania, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected March 28, 2017. Last inspected July 20, 2026.
Most cited issue areas
- Case history records- inadequate or inadequate1 inspection
- FD-1572, protocol compliance1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 20, 2026 | Not classified | Human Drugs | 1331848 |
| March 28, 2017 | VAI | Human Drugs · Bioresearch Monitoring | 1017164 |
FDA documents
Form 483s (1)
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Charu Aggarwal, MD, MPH, Hematology-Oncology Division
FEI Number
3013007367
Address
HUP, Penn Medicine, 3400 Civic Center Bl, Philadelphia, Pennsylvania 19104, United States
Country
United States
ID: 8e6529bd-6bbe-400c-a06b-816a5ff26a98